These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9575571)
1. The molecular basis for therapeutic concepts utilizing CD14. Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571 [TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14. Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028 [TBL] [Abstract][Full Text] [Related]
3. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation. Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200 [TBL] [Abstract][Full Text] [Related]
5. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845 [TBL] [Abstract][Full Text] [Related]
6. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. Vita N; Lefort S; Sozzani P; Reeb R; Richards S; Borysiewicz LK; Ferrara P; Labéta MO J Immunol; 1997 Apr; 158(7):3457-62. PubMed ID: 9120307 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes. Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818 [TBL] [Abstract][Full Text] [Related]
8. Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide. Stelter F; Loppnow H; Menzel R; Grunwald U; Bernheiden M; Jack RS; Ulmer AJ; Schütt C J Immunol; 1999 Dec; 163(11):6035-44. PubMed ID: 10570291 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. Hailman E; Vasselon T; Kelley M; Busse LA; Hu MC; Lichenstein HS; Detmers PA; Wright SD J Immunol; 1996 Jun; 156(11):4384-90. PubMed ID: 8666811 [TBL] [Abstract][Full Text] [Related]
10. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085 [TBL] [Abstract][Full Text] [Related]
11. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Su GL; Goyert SM; Fan MH; Aminlari A; Gong KQ; Klein RD; Myc A; Alarcon WH; Steinstraesser L; Remick DG; Wang SC Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G640-5. PubMed ID: 12181178 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418 [TBL] [Abstract][Full Text] [Related]
13. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. Delude RL; Yoshimura A; Ingalls RR; Golenbock DT J Immunol; 1998 Sep; 161(6):3001-9. PubMed ID: 9743364 [TBL] [Abstract][Full Text] [Related]
14. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. Jack RS; Grunwald U; Stelter F; Workalemahu G; Schütt C Eur J Immunol; 1995 May; 25(5):1436-41. PubMed ID: 7539760 [TBL] [Abstract][Full Text] [Related]
15. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14. Yu B; Wright SD J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357 [TBL] [Abstract][Full Text] [Related]
16. Moesin: a potential LPS receptor on human monocytes. Amar S; Oyaisu K; Li L; Van Dyke T J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582 [TBL] [Abstract][Full Text] [Related]
17. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. Pollack M; Ohl CA; Golenbock DT; Di Padova F; Wahl LM; Koles NL; Guelde G; Monks BG J Immunol; 1997 Oct; 159(7):3519-30. PubMed ID: 9317151 [TBL] [Abstract][Full Text] [Related]
18. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Blais DR; Vascotto SG; Griffith M; Altosaar I Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. Savedra R; Delude RL; Ingalls RR; Fenton MJ; Golenbock DT J Immunol; 1996 Sep; 157(6):2549-54. PubMed ID: 8805656 [TBL] [Abstract][Full Text] [Related]
20. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]